Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for March 22nd

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 22nd:

Fuel Tech, Inc. (FTEK - Free Report) : This provider of boiler optimization, efficiency improvement, and air pollution reduction and control solutions has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Fuel Tech’s shares gained 19.7% over the last one month against the S&P 500’s rise of 2.2%. The company possesses a Momentum Score of A.

Sanderson Farms, Inc. (SAFM - Free Report) : This integrated poultry processing company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Sanderson Farms’ shares gained 7% over the last one month. The company possesses a Momentum Score of B.

Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA - Free Report) : This cement and its by-products manufacturer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 30.4% over the last 60 days.

Loma’s shares gained 2.4% over the last one month. The company possesses a Momentum Score of B.

The Middleby Corporation (MIDD - Free Report) : This foodservice, food processing and residential kitchen equipment manufacturer has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1% over the last 60 days.

Middleby’s shares gained 7.4% over the last one month. The company possesses a Momentum Score of B.

See the full list of top ranked stocks here.

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



More from Zacks Zacks #1 Rank Additions

You May Like

Published in